These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
442 related articles for article (PubMed ID: 11409797)
21. [Interest of sentinel lymph node biopsy for the staging of ductal carcinoma in situ]. Buttarelli M; Houvenaeghel G; Martino M; Rossi I; Ronda I; Ternier F; Tallet A; Jacquemier J Ann Chir; 2004 Nov; 129(9):508-12. PubMed ID: 15556580 [TBL] [Abstract][Full Text] [Related]
22. Predictors of invasion in patients with core-needle biopsy-diagnosed ductal carcinoma in situ and recommendations for a selective approach to sentinel lymph node biopsy in ductal carcinoma in situ. Huo L; Sneige N; Hunt KK; Albarracin CT; Lopez A; Resetkova E Cancer; 2006 Oct; 107(8):1760-8. PubMed ID: 16977650 [TBL] [Abstract][Full Text] [Related]
23. Sentinel lymph node positivity of patients with ductal carcinoma in situ or microinvasive breast cancer. Katz A; Gage I; Evans S; Shaffer M; Fleury T; Smith FP; Flax R; Drogula C; Petrucci P; Magnant C Am J Surg; 2006 Jun; 191(6):761-6. PubMed ID: 16720145 [TBL] [Abstract][Full Text] [Related]
24. Tumour-positive sentinel node findings in patients with ductal carcinoma in situ. Leidenius M; Salmenkivi K; von Smitten K; Heikkilä P J Surg Oncol; 2006 Oct; 94(5):380-4. PubMed ID: 16967467 [TBL] [Abstract][Full Text] [Related]
25. Ductal carcinoma in situ with microinvasion: prognostic implications, long-term outcomes, and role of axillary evaluation. Parikh RR; Haffty BG; Lannin D; Moran MS Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):7-13. PubMed ID: 20950955 [TBL] [Abstract][Full Text] [Related]
26. Factors associated with lymph node assessment in ductal carcinoma in situ: analysis of 1988-2002 seer data. Porembka MR; Abraham RL; Sefko JA; Deshpande AD; Jeffe DB; Margenthaler JA Ann Surg Oncol; 2008 Oct; 15(10):2709-19. PubMed ID: 18483831 [TBL] [Abstract][Full Text] [Related]
28. Is there an indication for sentinel node biopsy in patients with ductal carcinoma in situ of the breast? A review. van Deurzen CH; Hobbelink MG; van Hillegersberg R; van Diest PJ Eur J Cancer; 2007 Apr; 43(6):993-1001. PubMed ID: 17300928 [TBL] [Abstract][Full Text] [Related]
29. Sentinel lymph node biopsy: is it indicated in patients with high-risk ductal carcinoma-in-situ and ductal carcinoma-in-situ with microinvasion? Klauber-DeMore N; Tan LK; Liberman L; Kaptain S; Fey J; Borgen P; Heerdt A; Montgomery L; Paglia M; Petrek JA; Cody HS; Van Zee KJ Ann Surg Oncol; 2000 Oct; 7(9):636-42. PubMed ID: 11034239 [TBL] [Abstract][Full Text] [Related]
30. [Importance of sentinel lymph node biopsy in surgical therapy of in situ breast cancer]. Takács T; Szentpáli K; Paszt A; Ormándi K; Lázár M; Pálka I; Kahán Z; Lázár G Magy Onkol; 2006; 50(3):247-51. PubMed ID: 17099786 [TBL] [Abstract][Full Text] [Related]
31. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients. Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881 [TBL] [Abstract][Full Text] [Related]
32. The role of sentinel lymph node biopsy in ductal carcinoma in situ. Moran CJ; Kell MR; Kerin MJ Eur J Surg Oncol; 2005 Dec; 31(10):1105-11. PubMed ID: 16084681 [TBL] [Abstract][Full Text] [Related]
33. The impact of sentinel lymph node biopsy in patients with a core biopsy diagnosis of ductal carcinoma in situ. Hung WK; Ying M; Chan M; Mak KL; Chan LK Breast Cancer; 2010 Oct; 17(4):276-80. PubMed ID: 19756924 [TBL] [Abstract][Full Text] [Related]
34. Microinvasive breast cancer and the role of sentinel node biopsy: an institutional experience and review of the literature. Guth AA; Mercado C; Roses DF; Darvishian F; Singh B; Cangiarella JF Breast J; 2008; 14(4):335-9. PubMed ID: 18537917 [TBL] [Abstract][Full Text] [Related]
35. Occult "micrometastases" in ductal carcinoma in situ: investigative implications for sentinel lymph node biopsy. Weaver DL Cancer; 2003 Nov; 98(10):2083-7. PubMed ID: 14601075 [No Abstract] [Full Text] [Related]
36. Sentinel lymph node biopsy is not necessary in patients diagnosed with ductal carcinoma in situ of the breast by stereotactic vacuum-assisted biopsy. Kotani H; Yoshimura A; Adachi Y; Ishiguro J; Hisada T; Ichikawa M; Gondou N; Hattori M; Kondou N; Sawaki M; Fujita T; Iwata H Breast Cancer; 2016 Mar; 23(2):190-4. PubMed ID: 24989112 [TBL] [Abstract][Full Text] [Related]
37. The relevance of occult axillary micrometastasis in ductal carcinoma in situ: a clinicopathologic study with long-term follow-up. Lara JF; Young SM; Velilla RE; Santoro EJ; Templeton SF Cancer; 2003 Nov; 98(10):2105-13. PubMed ID: 14601079 [TBL] [Abstract][Full Text] [Related]
38. Breast ductal carcinoma in situ with microinvasion: a definition supported by a long-term study of 1248 serially sectioned ductal carcinomas. de Mascarel I; MacGrogan G; Mathoulin-Pélissier S; Soubeyran I; Picot V; Coindre JM Cancer; 2002 Apr; 94(8):2134-42. PubMed ID: 12001109 [TBL] [Abstract][Full Text] [Related]
39. Symmetrization reduction mammaplasty combined with sentinel node biopsy in patients operated for contralateral breast cancer. Schrenk P; Wölfl S; Bogner S; Huemer GM; Wayand W J Surg Oncol; 2006 Jul; 94(1):9-15. PubMed ID: 16788937 [TBL] [Abstract][Full Text] [Related]
40. The value of sentinel lymph node biopsy in ductal carcinoma in situ (DCIS) and DCIS with microinvasion of the breast. van la Parra RF; Ernst MF; Barneveld PC; Broekman JM; Rutten MJ; Bosscha K Eur J Surg Oncol; 2008 Jun; 34(6):631-5. PubMed ID: 17851019 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]